Related Stories

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

2025/04/29/02:53:54
Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進 Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進

Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進

2025/04/29/01:53:30
STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions

STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions

2025/04/29/00:54:08

You may have missed

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

2025/04/29/02:53:54
Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進 Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進

Hikvisionが2024年度のESGレポートを発表―より良い未来に向けてTHRIVEを推進

2025/04/29/01:53:30
STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions

STRADVISION and Axera Announce Strategic Collaboration to Deliver Competitive ADAS and AD Solutions

2025/04/29/00:54:08
Hikvision、2024年度通期および2025年度第1四半期の業績を発表:視覚、言語、マルチモーダル機能などを統合したGuanlan Large-Scale AI Modelsにより、AIoTテクノロジーを積極的に推進 Hikvision、2024年度通期および2025年度第1四半期の業績を発表

Hikvision、2024年度通期および2025年度第1四半期の業績を発表:視覚、言語、マルチモーダル機能などを統合したGuanlan Large-Scale AI Modelsにより、AIoTテクノロジーを積極的に推進

2025/04/29/00:53:41
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied